Authors: Spaepen, K Stroobants, S Dupont, P Van Steenweghen, S Thomas, J Vandenberghe, P Vanuytsel, L Bormans, G Balzarini, J De Wolf-Peeters, C Mortelmans, L Verhoef, G

Citation: K. Spaepen et al., Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([F-18]FDG) after first-line chemotherapy in non-Hodgkin'slymphoma: Is [F-18]FDG-PET a valid alternative to conventional diagnostic methods?, J CL ONCOL, 19(2), 2001, pp. 414-419

Authors: Spaepen, K Stroobants, S Dupont, P Thomas, J Vandenberghe, P Balzarini, J De Wolf-Peeters, C Mortelmans, L Verhoef, G

Citation: K. Spaepen et al., Can positron emission tomography with [F-18]-fluorodeoxyglucose after first-line treatment distinguish Hodgkin's disease patients who need additionaltherapy from others in whom additional therapy would mean avoidable toxicity?, BR J HAEM, 115(2), 2001, pp. 272-278